✦ LIBER ✦

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer

✍ Scribed by Giuseppe D’Agostino; Frederic Amant; Patrick Berteloot; Giovanni Scambia; Ignace Vergote

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine and weekly

✍ Agustin A Garcia; Anne O'Meara; Ashim Bahador; Grace Facio; Susan Jeffers; Dae-Y 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Phase II Study of Gemcitabine and Doceta

✍ Garcia, Agustin A.; Yessaian, Anne; Pham, Huyen; Facio, Grace; Muderspach, Laila 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 177 KB

A phase II study of gemcitabine plus car

✍ M.F. Kose; J. Sufliarsky; S. Beslija; P. Saip; G. Tulunay; K. Krejcy; T. Minarik 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Topotecan in Platinum- and Paclitaxel-Re

✍ Elizabeth M. Swisher; David G. Mutch; Janet S. Rader; Alaa Elbendary; Thomas J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Phase 2 trial of single-agent gemcitabin

✍ Maurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peters 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase II trial of carboplatin and infusi

✍ Robert J. Morgan; Timothy W. Synold; David Gandara; Franco Muggia; Sidney Scudde 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 215 KB